Acadia Pharma's psychosis drug proven better than placebo in dementia patients

Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news